| In vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior A Zomer, C Maynard, FJ Verweij, A Kamermans, R Schäfer, E Beerling, ... Cell 161 (5), 1046-1057, 2015 | 901 | 2015 |
| Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer RJA Nilsson, N Karachaliou, J Berenguer, A Gimenez-Capitan, ... Oncotarget 7 (1), 1066, 2016 | 201 | 2016 |
| Probucol increases glutathione peroxidase-1 activity and displays long-lasting protection against methylmercury toxicity in cerebellar granule cells M Farina, F Campos, I Vendrell, J Berenguer, M Barzi, S Pons, C Suñol Toxicological Sciences 112 (2), 416-426, 2009 | 165 | 2009 |
| Sensing of latent EBV infection through exosomal transfer of 5′ pppRNA SR Baglio, MAJ van Eijndhoven, D Koppers-Lalic, J Berenguer, ... Proceedings of the National Academy of Sciences 113 (5), E587-E596, 2016 | 163 | 2016 |
| Altered lignin biosynthesis improves cellulosic bioethanol production in transgenic maize plants down-regulated for cinnamyl alcohol dehydrogenase S Fornalé, M Capellades, A Encina, K Wang, S Irar, C Lapierre, K Ruel, ... Molecular Plant 5 (4), 817-830, 2012 | 154 | 2012 |
| Sonic-hedgehog-mediated proliferation requires the localization of PKA to the cilium base M Barzi, J Berenguer, A Menendez, R Alvarez-Rodriguez, S Pons Journal of cell science 123 (1), 62-69, 2010 | 117 | 2010 |
| Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8 J Berenguer, T Lagerweij, XW Zhao, S Dusoswa, P Van Der Stoop, ... Journal of extracellular vesicles 7 (1), 1446660, 2018 | 89 | 2018 |
| Common co-activation of AXL and CDCP1 in EGFR-mutation-positive non-small cell lung cancer associated with poor prognosis N Karachaliou, I Chaib, AF Cardona, J Berenguer, JWP Bracht, J Yang, ... EBioMedicine 29, 112-127, 2018 | 82 | 2018 |
| Bone morphogenetic protein 2 opposes Shh-mediated proliferation in cerebellar granule cells through a TIEG-1-based regulation of Nmyc R Álvarez-Rodríguez, M Barzi, J Berenguer, S Pons Journal of Biological Chemistry 282 (51), 37170-37180, 2007 | 80 | 2007 |
| The combination of checkpoint immunotherapy and targeted therapy in cancer N Karachaliou, M Gonzalez-Cao, A Sosa, J Berenguer, JWP Bracht, M Ito, ... Annals of translational medicine 5 (19), 2017 | 77 | 2017 |
| The present and future of liquid biopsies in non-small cell lung cancer: combining four biosources for diagnosis, prognosis, prediction, and disease monitoring JWP Bracht, C Mayo-de-Las-Casas, J Berenguer, N Karachaliou, ... Current Oncology Reports 20, 1-10, 2018 | 75 | 2018 |
| BRAF Mutations Classes I, II, and III in NSCLC Patients Included in the SLLIP Trial: The Need for a New Pre-Clinical Treatment Rationale JWP Bracht, N Karachaliou, T Bivona, RB Lanman, I Faull, RJ Nagy, ... Cancers 11 (9), 1381, 2019 | 65 | 2019 |
| Integrin-linked kinase (ILK) and src homology 2 domain-containing phosphatase 2 (SHP2): Novel targets in EGFR-mutation positive non-small cell lung cancer (NSCLC) N Karachaliou, AF Cardona, JWP Bracht, E Aldeguer, A Drozdowskyj, ... EBioMedicine 39, 207-214, 2019 | 45 | 2019 |
| Cancer stem cell biomarkers in egfr-mutation–positive non–small-cell lung cancer J Codony-Servat, C Codony-Servat, AF Cardona, A Giménez-Capitán, ... Clinical Lung Cancer 20 (3), 167-177, 2019 | 43 | 2019 |
| STAT3 as a potential immunotherapy biomarker in oncogene-addicted non-small cell lung cancer I Attili, N Karachaliou, L Bonanno, J Berenguer, J Bracht, J Codony-Servat, ... Therapeutic Advances in Medical Oncology 10, 1758835918763744, 2018 | 40 | 2018 |
| MicroRNA 22 regulates cell cycle length in cerebellar granular neuron precursors J Berenguer, A Herrera, L Vuolo, B Torroba, F Llorens, L Sumoy, S Pons Molecular and cellular biology 33 (14), 2706-2717, 2013 | 38 | 2013 |
| LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer I Pérez-Núñez, C Rozalen, JÁ Palomeque, I Sangrador, M Dalmau, ... Nature cancer 3 (3), 355-370, 2022 | 37 | 2022 |
| Osimertinib and pterostilbene in EGFR-mutation-positive non-small cell lung cancer (NSCLC) JWP Bracht, N Karachaliou, J Berenguer, C Pedraz-Valdunciel, M Filipska, ... International journal of biological sciences 15 (12), 2607, 2019 | 22 | 2019 |
| Anaplastic lymphoma kinase inhibitors in phase I and phase II clinical trials for non-small cell lung cancer N Karachaliou, M Santarpia, M Gonzalez Cao, C Teixido, AE Sosa, ... Expert Opinion on Investigational Drugs 26 (6), 713-722, 2017 | 17 | 2017 |
| Hsp90 inhibitors enhance the antitumoral effect of osimertinib in parental and osimertinib-resistant non-small cell lung cancer cell lines J Codony-Servat, S Viteri, C Codony-Servat, M Ito, JWP Bracht, ... Translational lung cancer research 8 (4), 340, 2019 | 15 | 2019 |
